Reliability, quality and accuracy are the core of everything we do


The consultancy services offered by GW PharmaConsult will support you to create robust formulations and feasible production processes based on long experience within the pharmaceutical industry

The key values of our provided services are

  • Reliability
  • Quality
  • Accuracy
Image Description

GW PharmaConsult is a young company, established by myself in 2017. After 30 years in development and production for German (Klinge Pharma, Temmler Werke) and international companies (Fujisawa/Astellas (Japan) and SwissCaps/Aenova (Switzerland)), I invite you to benefit from this experience.

I am a pharmacist with a long experience and specialization in formulation development of generic APIs and NCEs. My main interests and strengths are characterized by the development of solid dosage forms, tablets, effervescent tablets, orodispersible granules, functionally coated multiple units, hard capsules and soft capsules, including scale-up to production (e.g. for omeprazole also as a combination with diclofenac-sodium following a patented process).

Gerd Weiss (Ph.D.), Pharmacist
- visit me on LinkedIn

See my Publications and Patents

See my References

SwissCaps AG/Aenova Group, Kirchberg, Switzerland (2013 – 2017)
Head of R&D Department
  • Development of soft capsules
  • Optimization/re-formulation/transfer of existing soft capsule products
Temmler Werke GmbH, Munich (2007 – 2013)
Head of Formulation Development
  • Development of solid and liquid drug products
  • Technology transfer and scale-up for contract manufacturing
Astellas Germany GmbH / Temmler Werke GmbH, Munich (2005 – 2007)
Manager Bulk Production
  • Commercial bulk manufacturing of solid and liquid drug products
  • Optimization/re-formulation of existing drug products
Fujisawa Germany GmbH, Munich (2001 – 2005)
Head of Formulation Development
  • Early stage formulation development of NCEs for dermal POC clinical studies
  • Global formulation development of NCEs as film-coated tablets following internal development guidelines
Klinge Pharma GmbH, Munich (1994 – 2001)
Group Leader Formulation Development
  • Project management of Protopic® ointment CTM manufacture for worldwide clinical trial supply
  • Formulation development of solid, semisolid and liquid generic drug products
Fujisawa Pharmaceuticals Co. Ltd., Osaka, Japan (1992 – 1993)
Researcher Technological Development Labs
  • Know-how transfer with Japanese parent company
Klinge Pharma GmbH, Munich (1987 – 1992)
Researcher Formulation Development
  • Formulation development of solid, semisolid and liquid generic drug products

Graduate studies in pharmaceutical technology at the University of Regensburg (1987-1992) under the supervision of Prof. Dr. H. Rupprecht. Title of Ph.D. thesis: “Microencapsulation of ibuprofen with enteric polymers by simple coacervation“

Studies in chemistry and major studies in pharmacy at the University of Würzburg, State examination as pharmacist.